Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3365 results

Sort By:

Menopausal HT for Women Living With HIV (HoT)

Study ID: NCT06856174
Start Date: 2025-06-18
End Date: 2026-10-19
Study Type

Interventional

Study Phase

Phase4

No. of Participants

105

Intervention / Treatment

Transdermal estradiol gel

Micronized Progesterone

Placebo for estradiol gel

Placebo for micronized progesterone

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Source: clinicaltrials.gov

Share:
Add to list

This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer

Study ID: NCT06882174
Start Date: 2025-10-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

58

Intervention / Treatment

Scheduling of the time of pembrolizumab infusions

Sponsor

AHS Cancer Control Alberta

Source: clinicaltrials.gov

Share:
Add to list

Targeted Transcranial Magnetic Stimulation to Improve Language and Speech in Patients With Primary Progressive Aphasia

Study ID: NCT06921265
Start Date: 2025-07-15
End Date: 2029-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

Training with Speech Language Therapy

Standard rTMS

Targeted rTMS

Standard rTMS (first cycle)

Standard rTMS (second cycle)

Targeted rTMS (first cycle)

Targeted rTMS (second cycle)

Sponsor

IRCCS San Raffaele

Source: clinicaltrials.gov

Share:
Add to list

AI-guided TIPS Procedure

Study ID: NCT06837974
Start Date: 2025-07-01
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

AI guided TIPS

Artificially blinded TIPS

Sponsor

Wuhan Union Hospital, China

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

Study ID: NCT06953466
Start Date: 2025-06-30
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

8

Intervention / Treatment

QRX003, 4% Lotion

Sponsor

Quoin Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

Study ID: NCT06919874
Start Date: 2025-09-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Thinking out Loud Session

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Study ID: NCT06919965
Start Date: 2025-08-25
End Date: 2032-02-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

220

Intervention / Treatment

TAR-210

Mitomycin C

Gemcitabine

Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices

Study ID: NCT06909682
Start Date: 2025-08-01
End Date: 2027-02-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

205

Intervention / Treatment

Intervention Group (Device Group - AI-Based Remote Monitoring)

Standard Clinical Follow-Up

Sponsor

University of Salerno

Source: clinicaltrials.gov

Share:
Add to list

Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene

Study ID: NCT06052631
Start Date: 2025-05-07
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment
Sponsor

National Center for Complementary and Integrative Health (NCCIH)

Source: clinicaltrials.gov

Share:
Add to list

Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)

Study ID: NCT06696131
Start Date: 2025-09-15
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

5

Intervention / Treatment

TNK

Sponsor

Gaurav Gupta, MD

Source: clinicaltrials.gov

Share:
Add to list